Resources for consultants

Durable cell and gene therapies are here. Paying for Cures in the MIT NEWDIGS FoCUS Project is your source for thoughtful, thorough, and inclusive strategies to grapple with the emerging challenges of making them accessible and sustainable.
Featured video

Paying for Cures: Framing the Issues

What are the special financing and reimbursement challenges presented by cell and gene therapies? Dr Jane Barlow outlines the basics.
Image
Overview

Ensuring patient access and system sustainability

Durable, potentially curative therapies for genetic disorders and cancer have arrived. Short—even single dose—treatment regimens yield lasting health benefits, but large single payments will challenge the current reimbursement system.

Policy, regulations, and business operations need to evolve to enable emerging solutions. Now is the time to implement precision financing solutions to ensure patient access and system sustainability.

Explore the Paying for Cures website

Three threads through the eye of a needle
Deep dive

Precision Financing Strategies

This comprehensive white paper lays out the practices and tools that can help make durable therapies sustainable by the healthcare system.

Download the white paper

Toolbox with research papers and calculators coming out
Hands-on

Paying for Cures Toolkit

The FoCUS Project at MIT NEWDIGS has developed this Toolkit as a resource for practitioners facing the financial challenges of offering, choosing, reimbursing or supporting an advanced durable therapy.

Use the toolkit to assess your situation, survey potential solutions, and start planning for success.

Open the Toolkit


Send feedback

We want to know what works for you, and what doesn't. Please share your thoughts with us!

    Subscribe to news

    Join our mailing list to keep up to date on Paying for Cures news and events. 


    Image

    Paying for Cures is an initiative of the FoCUS Project at MIT

    FoCUS seeks to collaboratively address the need for new, innovative financing and reimbursement models for durable therapies that ensure patient access and sustainability for all stakeholders. This multi-stakeholder effort unites developers, providers, regulators, patient advocacy groups, payers from all segments of the US healthcare system, and academics working in healthcare policy, financing, and reimbursement.

    FoCUS research and design

    • Engaged cross-sector, multi-stakeholder group to identify challenges and cooperatively design sustainable solutions
    • Analyzed drug pipeline to understand scale of the challenge
    • Described system of “Cure Archetypes” and how different kinds of healthcare payers can support them
    • Designed and served as a catalyst for Precision Financing pilots to test real-world application

    MIT Center for Biomedical Innovation
    NEWDIGS Initiative
    Massachusetts Institute of Technology
    E19–604
    77 Massachusetts Avenue
    Cambridge, MA 02139

    newdigs@mit.edu
    Phone: 617-324-9640
    Fax: 617-253-0687

    Image Image